Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF in Patients With ALI/ARDS
NCT00201409Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Jul 2004
- Primary completion
- May 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in acute respiratory distress syndrome (ARDS), acute lung injury (ALI), sponsored by University of Michigan. Started Jul 2004; status: completed.
02
Drugs
sargramostim
03
Conditions
acute respiratory distress syndrome (ARDS)acute lung injury (ALI)
Beyond the preview
Go deeper on NCT00201409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201409.